This inventor holds 2 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Alfact Innovation, National Institute of Health and Medical Research, Université Paris—sud. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 1,853 
2 out of 100 
Years Active: 2016-2017
Title: The Innovations of Gilles Amouyal
Introduction
Gilles Amouyal is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the areas of insulin resistance and cancer treatment. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Amouyal's latest patents include a composition that features the HIP/PAP protein or its derivatives for treating insulin resistance. This invention focuses on the use of the HIP/PAP protein to treat or prevent insulin resistance in non-insulin dependent subjects. Additionally, he has developed a patent concerning the HIP/PAP protein or its derivatives for use in treating or managing cancer, specifically targeting solid tumors.
Career Highlights
Throughout his career, Gilles Amouyal has worked with prominent organizations such as Alfact Innovation and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Amouyal has collaborated with several professionals in his field, including Paul Amouyal and Marion Darnaud. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in medical research.
Conclusion
Gilles Amouyal's contributions to the fields of insulin resistance and cancer treatment through his patents demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile